Conference Home

banner: 2016 best of lung cancer summmit

Conference Home

Scientific Agenda

Accommodations & Travel

Sponsorship

Symposium:
Breakfast
Lunch

The Best of Lung Cancer Summit

Canadian Oncology Societies, in partnership with OncologyEducation, is proud to host The Best of Lung Cancer Summit, taking place at The Westin Prince Hotel in Toronto, Ontario. This full-day event takes the most significant lung cancer data from the ASCO 2016 and ESMO 2016 conferences, and puts it into context for oncology professionals. Speakers will review the latest research with in-depth analysis and discussion to improve the current standard of lung cancer care. This event will be Co-Chaired by Dr. Barb Melosky and Dr. Ronald Burkes. 

OE Link Pilot Program – A live web streamed pilot program making information and practice changing data more accessible to physicians and allied health professionals located outside of the GTA. Fully interactive, allowing attendees to ask questions.

Register Now for our New OE Link Events in London, Sault Ste. Marie, Sudbury and Kingston.
Click Here for more information and registration.


Meeting Objectives

After taking part in the program, participants will be able to:
1. Describe the current and future availability and application of immunotherapy in the treatment of lung cancer.
2. Understand the latest strategies for managing lung cancer with radiation therapy and/or surgery.
3. Discuss approaches for maximizing outcomes on the standard of care in the management of lung cancer using biomarker testing, targeted therapies and other new targets.

 


FEES

Early Bird Price
(Ending September 23, 2016):

Nurses/Pharmacists/Residents/Allied Healthcare Providers: $39 CAD

Physicians: $59 CAD


Regular Price
(After September 23, 2016):

Nurses/Pharmacists/Residents/Allied Healthcare Providers: $59 CAD

Physicians: $99 CAD


ABOUT THE CHAIRS

Dr. Jean Maroun MD FRCPC FRCP(UK)

Chair of the Planning Committee

Dr. Maroun graduated from St. Joseph’s University, Beirut, Lebanon. He completed his training in Internal Medicine in England where he obtained the M.R.C.P. (UK) in 1973. He specialized in Medical Oncology at the University of Ottawa and in the Department of Developmental Therapeutics at the M.D. Anderson Cancer Centre, Houston, Texas, USA.

Dr. Maroun is a Professor of Medicine at the University of Ottawa and was nominated Fellow of the Royal College of Physicians of London, England in 1997. Until June 2002 Dr. Maroun was chair of Medical Oncology at the University of Ottawa and Head of Medical Oncology at the Ottawa Regional Cancer Centre and Ottawa Hospital.

Dr. Maroun was chair of the Ontario Provincial Gastro-Intestinal Practice Guidelines Committee. He is a past President of the Canadian Oncology Societies and the Canadian Association of Medical Oncologists. Dr. Maroun has long experience in the management of GI malignancies and has been involved in clinical research into new drugs development and new combinations in the treatment of colorectal cancer. His clinical and basic research focus is on Thymidylate Synthase Inhibitors and other predictors for targeted therapy.

Dr. Maroun has published extensively in peer reviewed journals and is involved provincially and nationally in numerous academic and research committees.

Dr. Ronald L. Burkes, MD, FRCPC

Dr. Burkes is a Professor of Medicine at the University of Toronto and a staff medical oncologist at Mount Sinai Hospital/Princess Margaret Cancer Centre/University Health Network in Toronto. He was the program director for the medical oncology training program at the University of Toronto from 1996 to 2005 and director of the Clinical Teaching Unit at PMH from 1999 to 2005.

He has won numerous teaching awards including departmental and university wide awards on ten occasions, the Anderson Award in Program Development, and the Hasselback Teaching Award at PMH. He has presented at many local, provincial, national and international meetings. His research interests include lung and GI malignancies and he has numerous publications including 58 peer reviewed, 109 non-peer reviewed, and two book chapters. 

Dr. Barbara Melosky, MD, FRCPC

Dr. Melosky is a Associate Professor of Medicine at the University of British Columbia and a Medical Oncologist at the British Columbia Cancer Agency. She graduated from medical school at the University of Manitoba and did a residency in internal medicine and a oncology fellowship at the University of British Columbia.

She is currently a medical oncologist at the BC Cancer Agency with clinical interests in lung and gastrointestinal malignancies.

 


**All continuing medical education credits are transferable between the USA and Canada.